UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 8-K 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of 

the Securities Exchange Act of 1934 

Date of report (Date of earliest event reported): March 1, 2017 (March 1, 2017) 

MEAD JOHNSON NUTRITION COMPANY 

(Exact Name of Registrant as Specified in Charter) 

  [DATA_TABLE_REMOVED] 

  2701 Patriot Blvd., Glenview, Illinois       60026   

  (Address of Principal Executive Offices)       (Zip Code)     

Registrant’s telephone number, including area code: (847) 832-2420 

Not Applicable 

(Former Name or Former Address, if Changed Since Last Report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 

x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Item 7.01: Regulation FD Disclosure. 

Mead Johnson Nutrition Company (the “Company”) is furnishing its press release dated March 1, 2017 announcing the declaration of a regular dividend on the Company’s common stock. The press release is included in this report as Exhibit 99.1 and is incorporated herein by reference. Pursuant to general instruction B.2 to Form 8-K, the information furnished pursuant to Item 7.01 shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. 

Item 8.01. Other Events. 

See “Item 7.01. Regulation FD Disclosure” above. 

Item 9.01: Financial Statements and Exhibits. 

(d) Exhibits 

  99.1       Press Release of Mead Johnson Nutrition Company dated March 1, 2017    

2 

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

  [DATA_TABLE_REMOVED] 

3